In contrast, imposing a clinically relevant period of prolonged CIS on the allografts prior to transplant increases the intensity of IRI-induced graft inflammation with marked increases in heterologous donor-reactive memory CD8+ T cell proliferation within the graft. The gene discussed is CD8A; the disease is in situ carcinoma.